Items where authors include "Gollins, S."

Article

Domingo, E., Rathee, S., Blake, A. et al. (22 more authors) (2024) Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGFβ as key predictors. EBioMedicine, 106. 105228. ISSN 2352-3964

Group, F.C., Glasbey, J., Beggs, A. et al. (430 more authors) (2024) Risk of Bowel Obstruction in Patients Undergoing Neoadjuvant Chemotherapy for High-risk Colon Cancer. Annals of Surgery, 280 (2). pp. 283-293. ISSN 0003-4932

Mahmood, U. orcid.org/0000-0002-2926-3205, Blake, A. orcid.org/0000-0002-8154-6253, Rathee, S. orcid.org/0000-0002-2853-0842 et al. (18 more authors) (2024) Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional Signatures. Cancer Research Communications, 4 (7). pp. 1765-1776. ISSN 2767-9764

Lafarge, M.W. orcid.org/0000-0001-9235-783X, Domingo, E. orcid.org/0000-0003-4390-8767, Sirinukunwattana, K. et al. (17 more authors) (2024) Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy. npj Precision Oncology, 8. 89. ISSN 2397-768X

Sebag-Montefiore, D. orcid.org/0000-0002-5978-9259, Adams, R., Gollins, S. et al. (17 more authors) (2020) ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC). Journal of Clinical Oncology, 38 (15_suppl). 4101. ISSN 0732-183X

Proceedings Paper

Domingo, E., Rathee, S., Blake, A. et al. (18 more authors) (2021) Abstract LB129: Stratification of radiotherapy and fluoropyrimidine-based chemotherapy from multi-omic profiling in rectal cancer biopsies. In: Cancer Research. AACR Annual Meeting 2021, 17-21 May 2021, Philadelphia, PA, USA. American Association for Cancer Research (AACR) , LB129.

Mukherjee, S., Hurt, C., Cox, C. et al. (17 more authors) (2020) Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial. In: Journal of Clinical Oncology. 2020 Gastrointestinal Cancers Symposium, 23-25 Jan 2020, San Francisco, CA, USA. American Society of Clinical Oncology , p. 373.